37
Views
7
CrossRef citations to date
0
Altmetric
Diagnostic Profile

A universal array-based multiplexed test for cystic fibrosis carrier screening

, , &
Pages 15-22 | Published online: 09 Jan 2014

References

  • Hamosh A, FitzSimmons SC, Macek M Jr, Knowles MR, Rosenstein BJ, Cutting GR. Comparison of the clinical manifestations of cystic fibrosis in black and white patients. J. Pediatr. 132(2), 255–259 (1998).
  • Grody WW, Cutting GR, Klinger KW et al. Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genet. Med. 3(2), 149–154 (2001).
  • Watson MS, Cutting GR, Desnick RJ et al. Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel. Genet. Med. 6(5), 387–391 (2004).
  • Strom CM, Crossley B, Redman JB et al. Cystic fibrosis screening: lessons learned from the first 320,000 patients. Genet. Med. 6(3), 136–140 (2004).
  • Janeczko R. Current methods for cystic fibrosis mutation detection. Advance Newsmagazines: Advance for Administrators of the Laboratory 13(4), 56–62 (2004).
  • Richards CS, Grody WW. Prenatal screening for cystic fibrosis: past, present and future. Expert Rev. Mol. Diagn. 4(1), 49–62 (2004).
  • Bortolin S, Black M, Modi H et al. Analytical validation of the Tag-It high-throughput microsphere-based universal array genotyping platform: application to the multiplex detection of a panel of thrombophilia-associated single-nucleotide polymorphisms. Clin. Chem. 50(11), 2028–2036 (2004).
  • Farrell MH, Farrell PM. Newborn screening for cystic fibrosis: ensuring more good than harm. J. Pediatr. 143(6), 707–712 (2003).
  • Sugarman EA, Rohlfs EM, Silverman LM, Allitto BA. CFTR mutation distribution among U.S. Hispanic and African American individuals: evaluation in cystic fibrosis patient and carrier screening populations. Genet. Med. 6(5), 392–399 (2004).
  • Buyse IM, McCarthy SE, Lurix P et al. Use of MALDI-TOF mass spectrometry in a 51-mutation test for cystic fibrosis: evidence that 3199del6 is a disease-causing mutation. Genet. Med. 6(5), 426–30 (2004).
  • Heim RA, Sugarman EA, Allitto BA. Improved detection of cystic fibrosis mutations in the heterogeneous U.S. population using an expanded, pan-ethnic mutation panel. Genet. Med. 3(3), 168–176 (2001).
  • Schrivjer I Oitmaa E, Metspalu A, Gardner P. Genotyping microarray for the detection of more than 200 CFTR mutations in ethnically diverse populations. J. Mol. Diagn. 7(3), 375–387 (2005).
  • Kaback M, Lim-Steele J, Dabholkar D, Brown D, Levy N, Zeiger K. Tay–Sachs disease-carrier screening, prenatal diagnosis, and the molecular era. An international perspective, 1970 to 1993. The International TSD Data Collection Network. JAMA 270(19), 2307–2315 (1993).
  • Palomaki GE, FitzSimmons SC, Haddow JE. Clinical sensitivity of prenatal screening for cystic fibrosis via CFTR carrier testing in a United States panethnic population. Genet. Med. 6(5), 405–414 (2004).
  • Palomaki GE. Prenatal screening for cystic fibrosis: an early report card. Genet. Med. 6(3), 115–116 (2004).

Website

  • American College of Medical Genetics: Technical Standards and Guidelines for CFTR Mutation Testing, 2005 Edition. www.acmg.net/Pages/ACMG_Activities/ stds-2002/cf.htm

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.